Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
melanoma
|
515 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.800 | 0.938 | 16 | 2001 | 2019 | |||||
Basal Cell Cancer
|
109 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 3 | 2011 | 2019 | |||||
Basal cell carcinoma
|
109 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 3 | 2011 | 2019 | |||||
Basal Cell Neoplasm
|
109 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 3 | 2011 | 2019 | |||||
Carcinoma, Basal Cell
|
91 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.730 | 1.000 | 3 | 2009 | 2015 | |||||
Cutaneous Melanoma
|
248 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.030 | 1.000 | 3 | 2009 | 2019 | |||||
Hair Color
|
312 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.800 | 1.000 | 3 | 2007 | 2018 | |||||
Skin Pigmentation
|
72 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 3 | 2013 | 2018 | |||||
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder)
|
13 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.030 | 1.000 | 3 | 2005 | 2008 | |||||
Experimental Organism Basal Cell Carcinoma
|
63 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||
Malignant neoplasm of skin
|
38 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.020 | 1.000 | 2 | 2002 | 2007 | |||||
Melanosis
|
23 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 2 | 2007 | 2018 | |||||
Carcinogenesis
|
355 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.010 | 1.000 | 1 | 2001 | 2001 | |||||
Congenital Mesoblastic Nephroma
|
5 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Freckles
|
10 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||
Hereditary Melanoma
|
67 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||
Huntington Disease
|
115 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Parkinson Disease
|
990 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Skin carcinoma
|
24 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Squamous cell carcinoma
|
257 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Squamous cell carcinoma of skin
|
92 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Suntan
|
94 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC (disorder)
|
2 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 0 | ||||||||
OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF
|
3 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 0 | ||||||||
SKIN/HAIR/EYE PIGMENTATION 2, RED HAIR/FAIR SKIN
|
3 | 0.695 | 0.280 | 16 | 89919709 | missense variant | C/A;G;T | snv | 4.4E-02 | 0.700 | 0 |